Download presentation
Presentation is loading. Please wait.
Published byHoward Harrell Modified over 6 years ago
1
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report Case Rep Ophthalmol 2016;7:389– DOI: / © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0
2
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report Case Rep Ophthalmol 2016;7:389– DOI: / © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0
3
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report Case Rep Ophthalmol 2016;7:389– DOI: / © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0
4
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report Case Rep Ophthalmol 2016;7:389– DOI: / © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.